Celtaxsys
Biopharmaceutical company, engages in developing and testing drug compounds for treating cancer.
Launch date
Market cap
-
Enterprise valuation
CAD245—368m (Dealroom.co estimates Jun 2015.)
Atlanta Georgia (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$5.2m | Series A | ||
$3.7m | Series B | ||
| N/A | $2.0m | Debt | |
| N/A | $4.2m | Early VC | |
$45.0m | Series D | ||
N/A | Series E | ||
$5.0m | Grant | ||
| Total Funding | CAD86.0m | ||
Related Content
Recent News about Celtaxsys
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.